Literature DB >> 20057420

Myelodysplasia: battle in the bone marrow.

Yan Liu, Takashi Asai, Stephen D Nimer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20057420     DOI： 10.1038/nm0110-30

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  14 in total

1.  Distinct haematological disorder with deletion of long arm of no. 5 chromosome.

Authors:  H Van den Berghe; J J Cassiman; G David; J P Fryns; J L Michaux; G Sokal
Journal:  Nature       Date:  1974-10-04       Impact factor: 49.962

2.  Lenalidomide in the myelodysplastic syndrome with chromosome 5q deletion.

Authors:  Alan List; Gordon Dewald; John Bennett; Aristotle Giagounidis; Azra Raza; Eric Feldman; Bayard Powell; Peter Greenberg; Deborah Thomas; Richard Stone; Craig Reeder; Kenton Wride; John Patin; Michele Schmidt; Jerome Zeldis; Robert Knight
Journal:  N Engl J Med       Date:  2006-10-05       Impact factor: 91.245

3.  Identification of miR-145 and miR-146a as mediators of the 5q- syndrome phenotype.

Authors:  Daniel T Starczynowski; Florian Kuchenbauer; Bob Argiropoulos; Sandy Sung; Ryan Morin; Andrew Muranyi; Martin Hirst; Donna Hogge; Marco Marra; Richard A Wells; Rena Buckstein; Wan Lam; R Keith Humphries; Aly Karsan
Journal:  Nat Med       Date:  2009-11-08       Impact factor: 53.440

4.  Long-term haematopoietic reconstitution by Trp53-/-p16Ink4a-/-p19Arf-/- multipotent progenitors.

Authors:  Omobolaji O Akala; In-Kyung Park; Dalong Qian; Michael Pihalja; Michael W Becker; Michael F Clarke
Journal:  Nature       Date:  2008-04-16       Impact factor: 49.962

5.  Ribosomal protein S19 deficiency in zebrafish leads to developmental abnormalities and defective erythropoiesis through activation of p53 protein family.

Authors:  Nadia Danilova; Kathleen M Sakamoto; Shuo Lin
Journal:  Blood       Date:  2008-05-30       Impact factor: 22.113

6.  p53 regulates hematopoietic stem cell quiescence.

Authors:  Yan Liu; Shannon E Elf; Yasuhiko Miyata; Goro Sashida; Yuhui Liu; Gang Huang; Silvana Di Giandomenico; Jennifer M Lee; Anthony Deblasio; Silvia Menendez; Jack Antipin; Boris Reva; Andrew Koff; Stephen D Nimer
Journal:  Cell Stem Cell       Date:  2009-01-09       Impact factor: 24.633

7.  Clonal heterogeneity in the 5q- syndrome: p53 expressing progenitors prevail during lenalidomide treatment and expand at disease progression.

Authors:  Martin Jädersten; Leonie Saft; Andrea Pellagatti; Gudrun Göhring; James S Wainscoat; Jacqueline Boultwood; Anna Porwit; Brigitte Schlegelberger; Eva Hellström-Lindberg
Journal:  Haematologica       Date:  2009-10-01       Impact factor: 9.941

8.  Ribosomal mutations cause p53-mediated dark skin and pleiotropic effects.

Authors:  Kelly A McGowan; Jun Z Li; Christopher Y Park; Veronica Beaudry; Holly K Tabor; Amit J Sabnis; Weibin Zhang; Helmut Fuchs; Martin Hrabé de Angelis; Richard M Myers; Laura D Attardi; Gregory S Barsh
Journal:  Nat Genet       Date:  2008-07-20       Impact factor: 38.330

Review 9.  MicroRNAs: key regulators of stem cells.

Authors:  Vamsi K Gangaraju; Haifan Lin
Journal:  Nat Rev Mol Cell Biol       Date:  2009-02       Impact factor: 94.444

10.  Haploinsufficiency of RPS14 in 5q- syndrome is associated with deregulation of ribosomal- and translation-related genes.

Authors:  Andrea Pellagatti; Eva Hellström-Lindberg; Aristoteles Giagounidis; Janet Perry; Luca Malcovati; Matteo G Della Porta; Martin Jädersten; Sally Killick; Carrie Fidler; Mario Cazzola; James S Wainscoat; Jacqueline Boultwood
Journal:  Br J Haematol       Date:  2008-05-08       Impact factor: 6.998
View more
  4 in total

1.  Clonal origin and evolution of myelodysplastic syndrome analyzed by dysplastic morphology and fluorescence in situ hybridization.

Authors:  Chun-Mei Fu; Zi-Xing Chen; Dan-Dan Liu; Jun Zhang; Jin-Lan Pan; Jian-Ying Liang
Journal:  Int J Hematol       Date:  2014-11-28       Impact factor: 2.490

2.  (2S,4R)-4-[18F]Fluoroglutamine as a PET Indicator for Bone Marrow Metabolism Dysfunctional: from Animal Experiments to Clinical Application.

Authors:  Hua Zhu; Fei Liu; Yan Zhang; Jianhua Yang; Xiaoxia Xu; Xiaoyi Guo; Teli Liu; Nan Li; Lin Zhu; Hank F Kung; Zhi Yang
Journal:  Mol Imaging Biol       Date:  2019-10       Impact factor: 3.488

3.  Annotating function to differentially expressed LincRNAs in myelodysplastic syndrome using a network-based method.

Authors:  Keqin Liu; Dominik Beck; Julie A I Thoms; Liang Liu; Weiling Zhao; John E Pimanda; Xiaobo Zhou
Journal:  Bioinformatics       Date:  2017-09-01       Impact factor: 6.937

4.  Mutated genes and driver pathways involved in myelodysplastic syndromes—a transcriptome sequencing based approach.

Authors:  Liang Liu; Hongyan Wang; Jianguo Wen; Chih-En Tseng; Youli Zu; Chung-che Chang; Xiaobo Zhou
Journal:  Mol Biosyst       Date:  2015-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.